Guardian Pharmacy Services, Inc. - CLASS A COMMON STOCK (GRDN)

CUSIP: 40145W101

Q1 2026 13F Holders as of 31 Mar 2026

Holder snapshot 6 signals
Share change
+8,053,218
SEC-reported price per share
$37.66
Number of holders
171
Value change
+$304,011,170
Number of buys
104
Number of sells
56
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
62,769,187

Security key

40145W101

Report period

Q1 2026

Institutions

171

Top holders

10

Ownership snapshot

Top reported holders of GRDN - Guardian Pharmacy Services, Inc. - CLASS A COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Alyeska Investment Group,...
Disclosed value leader
BlackRock, Inc.
Comparable rows
13/15
Latest evidence
31 Dec 2025
13D/G 13F Lead comparable stake: 4.7% 2 rows are not safely comparable across share classes. 13D/G row: Alyeska Investment Group, L.P. Showing 1-6 of 15 holder rows.

Quick read

Alyeska Investment Group, L.P. leads the comparable SEC ownership view at 4.7%.

13 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Alyeska Investment Group, L.P.'s linked filing trail.
Comparable ownership Top 5
Alyeska Investment Group, L.P. 4.7%
BROWN ADVISORY INC 4.5%
Woodline Partners LP 4.5%
FRANKLIN TEMPLETON INC 4.3%
VANGUARD GROUP INC 4.2%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Alyeska Investment Group, L.P.
13D/G
4.7%
Reported 13D/G · 31 Dec 2024
$10,328,537
428,570 shares
$0 31 Dec 2024
BROWN ADVISORY INC
13D/G 13F
Company
4.5%
Reported 13D/G · 31 Dec 2025
$49,485,081
1,644,569 shares
+$1,116,399 31 Dec 2025
Woodline Partners LP
13F 13D/G
Company
4.5%
Reported 13D/G · 31 Dec 2024
$31,712,032
1,053,906 shares
— 31 Dec 2025
FRANKLIN TEMPLETON INC
13F 13D/G
Company · Franklin Resources, Inc.
4.3%
Reported 13D/G · 30 Jun 2025
$29,830,684
991,382 shares
— 31 Dec 2025
VANGUARD GROUP INC
13F 13D/G
Company · The Vanguard Group
4.2%
Reported 13D/G · 30 Jun 2025
$40,725,640
1,353,461 shares
— 31 Dec 2025
BlackRock, Inc.
13F 13D/G
Company
4.2%
Reported 13D/G · 31 Dec 2025
$52,442,596
1,742,858 shares
— 31 Dec 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
171
Shares
28,318,060
Rows available
171
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2026 vs Q3 2025 Across Filers

Q3 2025 holders
111
Q1 2026 holders
171
Holder diff
60
Investor Q3 2025 Shares Q1 2026 Shares Share Diff Share Chg % Q3 2025 value Q1 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .